Healthy women help compare two versions of sotatercept
NCT ID NCT06930664
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 study tested two forms of the drug sotatercept in 146 healthy women who cannot become pregnant. One form is a liquid in an autoinjector pen, the other is a powder that must be mixed before injection. The goal was simply to see how the body absorbs and processes each version, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sotatercept
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Pharma CR, LLC ( Site 0005)
Miami, Florida, 33147, United States
-
Anaheim Clinical Trials ( Site 0007)
Anaheim, California, 92801, United States
-
Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0003)
Springfield, Missouri, 65802, United States
-
QPS-MRA, LLC ( Site 0004)
South Miami, Florida, 33143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test